Browse: Companies | People | Financial Organizations
Home > Financial Organizations > Frazier Healthcare Ventures

General Information

Websitefrazierhealthcare...
Phone206.621.7200
Employees
Founded1991

Funds

Offices

Seattle OFFICE
601 Union, Two Union Square, Suite 3200
Seattle, WA, 98101
USA
Menlo Park office
70 Willow Rd, Suite 200
Menlo Park, CA, 94025
USA

People

COO & General Partner
CFO

Tags

Frazier Healthcare Ventures

Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and growth equity capital to emerging biopharma, medical device and healthcare service companies. With over $1.8 billion under management, Frazier Healthcare has invested in over 100 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare Ventures has established itself among entrepreneurs and seasoned executives as the preferred partner to grow successful healthcare companies.

Milestones

Investments

Company Date Round Size Participants
Calypso Medical 11/09Series E$50M4
Barosense 8/09Series D$27M7
Calistoga 6/09Series B$30M4
Clovis Oncology 5/09Series A$145M7
Calistoga Pharmaceuticals 5/09Series B$30M4
Stemgent 3/09Series B$14M2
Primaeva Medical 2/09Series C$6M3
Intradigm Corporation 1/09Series B$21.4M8
Alnara Pharmaceuticals 10/08Series A$20M3
Glaukos 8/08Series D$35M7
PatientKeeper 8/08Series F$7.5M3
EBR Systems 6/08Series C$35M5
Nuon Therapeutics 4/08Series B$27M2
Stromedix 4/08Series B$25M5
Zonare Medical Systems 2/08Unattributed$30M8
PowerVision 12/07Series B$20M3
Zeltiq Aesthetics 10/07Series B$20.3M2
FlowCardia 8/07Series C$30M9

Videos

Sources

  1. Calypso Medical Technologies, Inc.: Series E $50M (onbiovc.com) [edit]
  2. Barosense bags $27M for obesity treatment (deals.venturebeat.com) [edit]
  3. Calistoga Pharmaceuticals, Inc.: Series B $30M (onbiovc.com) [edit]
  4. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  5. Capital Report Index [edit]
  6. Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers (xconomy.com) [edit]
  7. Primaeva Medical raises $6M for aging skin (deals.venturebeat.com) [edit]
  8. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]
  9. Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round (xconomy.com) [edit]
  10. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  11. Equity Help Desk (equityhelpdesk.com) [edit]
  12. Capital Funding Report [edit]
  13. Nuon Therapeutics, Inc. Completes $27 Million Series B Financing (nuontherapeutics.com) [edit]
  14. Capital Funding Report [edit]
  15. Compact-ultrasound maker Zonare Medical raises $30M (deals.venturebeat.com) [edit]
  16. VentureBeat (venturebeat.com) [edit]
  17. Zeltiq raises $20.3M for fat reduction (deals.venturebeat.com) [edit]
  18. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
Edit This Page
Last Edited 11/2/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy